Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FMYFE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,979
Award facts
- Contract value 100% obligated
- $31,979.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $31,979.27. This delivery order represents a firm fixed-price, non-set-aside award utilizing competitive procurement procedures. The contract is classified as a child award, indicating it falls under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialty pharmaceutical products for military and veteran healthcare systems.
This delivery order is part of AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded contracts demonstrates its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FMYFE?
SPE2DB25FMYFE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FMYFE worth?
The government has obligated $31,979 on SPE2DB25FMYFE.
Is contract SPE2DB25FMYFE an order under another contract?
Yes. SPE2DB25FMYFE is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMYFE competed?
The extent of competition for SPE2DB25FMYFE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award